We Accelerate Change...
TREAT-NMD is a global 爆奖视频，LIVE直播大公开澳洲体彩幸运5官网最新开奖号码结果的实况 network of experts in the neuromuscular field. Everyone in our 澳彩五票分析历史记录 奥洲5赛事查询 正规官方168网站 免费看直播，查询五分钟一期号码记录 专业预测全面的数据详情，导出走势图结果 network helps us work towards our mission to accelerate the development of effective treatments; and establish the best in diagnosis and care for people worldwide.
Join us for the DMD Industry Symposium
11 July @ 09:00 - 18:30 BST
TREAT-NMD is delighted to host a face-to-face, expert-led, one-day Symposium on
Duchenne Muscular Dystrophy (DMD).
Who We Support...
What We Do...@澳彩五票官网入口 168官网体彩，幸运赛事查询五分钟结果记录
Advisory Committee for Therapeutics
Evaluating the therapeutic potential of drugs to optimise their design and development.
Global Registry Network
A federated network of 65 individual, independent, national (or regional) patient registries that collect data on neuromuscular patients from more than 40 countries worldwide.
Education
Giving healthcare providers greater understanding of the diagnosis and management of neuromuscular diseases.
Post-Marketing Surveillance
TREAT-NMD contributes to post-marketing surveillance in the neuromuscular field by acting as an independent partner of Life Sciences Industry and Clinical Research Organisations to facilitate and contribute to international, disease specific PMS systems and processes to fulfil regulatory requirements.
Resources and Support
Providing information to patients and health care providers to improve patients’ diagnosis and care.
Connecting the Network
Bringing people together to accelerate cutting-edge therapies for otherwise unmet needs.
TREAT-NMD Latest News... 澳洲行运5开采时时网 实时更新最新消息 #澳洲幸运5开奖官网开奖
The Online Registry Portal Launch
We’re excited to announce the phased launch of the new online communication portal designed specifically for registry network curators. As previewed during the June subgroup meetings, the Registry Portal is now being […]
The TREAT-NMD Advisory Committee for Therapeutics (TACT)
The TREAT-NMD Advisory Committee for Therapeutics (TACT) is a globally recognised, multidisciplinary panel of experts that convenes several times a year to review and provide independent guidance on key aspects […]
Join us for the Becker Patient Education and Engagement Days – September 2025
TREAT-NMD is pleased to announce two upcoming Becker Education and Engagement Days taking place in September 2025, designed for individuals living with Becker muscular dystrophy, their families, and members of […]
Last Chance Early Bird Tickets for the TREAT-NMD International Conference – Lisbon, February 2026
As the neuromuscular field continues to evolve, so do the challenges we face – whether it’s ensuring equitable access to therapies, navigating regulatory uncertainty, or aligning with the expectations of […]
Harnessing Technology to Improve Lives in Neuromuscular Disease
TREAT-NMD is taking bold steps to ensure it remains at the forefront of innovation in rare disease care. As a global leader in advancing treatments for neuromuscular disease through education, […]
Upcoming TREAT-NMD SMA and DMD Expert Masterclasses, Prague
We are very pleased to be hosting another in our series of educational masterclasses in Prague next week. Across three days, we will run masterclasses aimed at healthcare professionals […]
Last chance to express your interest to attend the Duchenne Muscular Dystrophy Early Diagnosis Masterclass, hosted by TREAT-NMD and Parent Project Muscular Dystrophy (PPMD)!
If you are a healthcare professional involved in the diagnosis of patients living with Duchenne muscular dystrophy (DMD), we invite you to express your interest in attending a virtual masterclass. The […]
Duchenne Muscular Dystrophy Early Diagnosis Project
The increasing prevalence of newborn genetic screening has led to earlier DMD diagnoses, with more and more patients being diagnosed prior to the development of symptoms. However, minimal clinical guidance […]
